Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics

Multiple reaction monitoring mass spectrometry (MRM-MS) with stable isotope dilution (SID) is increasingly becoming a widely accepted assay for the quantification of proteins and peptides. These assays have shown great promise in relatively high throughput verification of candidate biomarkers. While...

Full description

Bibliographic Details
Main Authors: Mani, D. R. (Author), Abbatiello, Susan E (Author), Carr, Steven A (Author)
Other Authors: Koch Institute for Integrative Cancer Research at MIT (Contributor), Carr, Steven A. (Contributor)
Format: Article
Language:English
Published: BioMed Central Ltd, 2012-11-06T17:41:19Z.
Subjects:
Online Access:Get fulltext
Description
Summary:Multiple reaction monitoring mass spectrometry (MRM-MS) with stable isotope dilution (SID) is increasingly becoming a widely accepted assay for the quantification of proteins and peptides. These assays have shown great promise in relatively high throughput verification of candidate biomarkers. While the use of MRM-MS assays is well established in the small molecule realm, their introduction and use in proteomics is relatively recent. As such, statistical and computational methods for the analysis of MRM-MS data from proteins and peptides are still being developed. Based on our extensive experience with analyzing a wide range of SID-MRM-MS data, we set forth a methodology for analysis that encompasses significant aspects ranging from data quality assessment, assay characterization including calibration curves, limits of detection (LOD) and quantification (LOQ), and measurement of intra- and interlaboratory precision. We draw upon publicly available seminal datasets to illustrate our methods and algorithms.
National Cancer Institute (U.S.) (Grant U24CA126476)
National Heart, Lung, and Blood Institute (Grant HHSN268201000033C)